Utility of surveillance blood cultures in patients undergoing hematopoietic stem cell transplantation

[1] Collin BA(2001)Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients Clin Infect Dis 33 947-953

[2] Leather HL(1999)Early infections in patients undergoing bone marrow or blood stem cell transplantation – a 7 year single centre investigation of 409 cases Bone Marrow Transplant 23 589-597

[3] Wingard JR(2000)High rate of secondary viral and bacterial infections in patients undergoing allogenic bone marrow mini-transplantation Bone Marrow Transplant 26 251-255

[4] Ramphal R(2001)Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants Clin Infect Dis 33 41-47

[5] Krüger W(2002)Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study Blood 99 1978-1985

[6] Rüssmann B(1998)Early gram positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis Bone Marrow Transplant 21 173-180

[7] Kröger N(1997)Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation Bone Marrow Transplant 19 143-147

[8] Salomon C(1998)Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection Bone Marrow Transplant 22 795-800

[9] Ekopf N(2001)Cell-wall-deficient bacteria and culture-negative febrile episodes in bone-marrow-transplant recipients Lancet 357 675-679

[10] Elsner HA(2001)Cell-wall-deficient bacteria Lancet 357 1885-1886

[1] Collin BA(2001)Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients Clin Infect Dis 33 947-953

[2] Leather HL(1999)Early infections in patients undergoing bone marrow or blood stem cell transplantation – a 7 year single centre investigation of 409 cases Bone Marrow Transplant 23 589-597

[3] Wingard JR(2000)High rate of secondary viral and bacterial infections in patients undergoing allogenic bone marrow mini-transplantation Bone Marrow Transplant 26 251-255

[4] Ramphal R(2001)Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants Clin Infect Dis 33 41-47

[5] Krüger W(2002)Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study Blood 99 1978-1985

[6] Rüssmann B(1998)Early gram positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis Bone Marrow Transplant 21 173-180

[7] Kröger N(1997)Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation Bone Marrow Transplant 19 143-147

[8] Salomon C(1998)Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection Bone Marrow Transplant 22 795-800

[9] Ekopf N(2001)Cell-wall-deficient bacteria and culture-negative febrile episodes in bone-marrow-transplant recipients Lancet 357 675-679

[10] Elsner HA(2001)Cell-wall-deficient bacteria Lancet 357 1885-1886